What is the price of deuterated colexitinib (decavatinib) tablets? 2025 Selling Prices and Buying Suggestions
Decavatinib is a new type of oral selective tyrosine kinase 2 (TYK2) inhibitor, mainly used to treat immune-related diseases such as moderate to severe psoriasis. The drug has been successfully launched in China and has been included in the medical insurance catalog, which has greatly reduced the financial burden on patients. The price of domestic 6mg*7 tablets is about more than one thousand yuan, and it is more convenient for patients to buy it in regular hospitals or pharmacies.
In comparison, the US original research version of deuterated colexitinib is more expensive, with 6mg*30 tablets priced at nearly 50,000 yuan. This is mainly due to factors such as research and development costs, patent protection, and import taxes. The high price makes it unaffordable for some patients, so choosing domestic versions or generic drugs covered by medical insurance has become a realistic option.

In the international market, countries such as Laos and Bangladesh have launched generic versions of deuterated colexitinib that are officially on the market. The ingredients of these generic drugs are basically the same as those of the original drugs. The quality is strictly controlled and the price is relatively affordable. The price of 6mg*30 tablets is about four to five hundred yuan, which greatly improves the accessibility to patients. By purchasing generic drugs through formal channels, patients can not only ensure the safety of medication, but also save a lot of medical expenses.
Generally speaking, when choosing deuterated colexitinib, patients should give priority to drugs that have been included in domestic medical insurance, which not only ensures the quality of the drug, but also enjoys preferential medical insurance reimbursement. If you have special needs or price considerations, you can also choose certified overseas generic drugs, but be sure to purchase them through formal channels and use them rationally under the guidance of a doctor to ensure therapeutic effects and drug safety.
Reference materials:https://go.drugbank.com/drugs/DB16650
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)